The Global Alzheimer’s Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer’s and Parkinson’s by reducing the time and cost of Alzheimer’s disease (AD) and Parkinson’s disease (PD) clinical trials.
What We Do
436 Years–That is how much clinical trial experience we bring to the table.
GAP, collectively, has expertise in nearly every area of neurology including Alzheimer’s and Parkinson’s disease, epilepsy, mental health, Down Syndrome, TBI and stroke. Finding treatments and cures for neurodegenerative diseases requires multi-layered, diverse backgrounds of clinical research, and we believe we have assembled the best team to contribute to the field
GAP works with international organizations that share our goals for clinical trial innovation. GAP regularly engages with global partners to coordinate efforts, share information and maintain open dialogue with initiatives under development around the world.